INLINE OPTIONSSCHEIN - PFIZER INC | Real-time Bid/Ask 07:57:17 2024-06-03 am EDT | ||
| 4.25 EUR / 4.39 EUR | -7.10% |
|
| 1 month | -30.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 3.94 | -15.27% |
| 24-05-31 | 4.65 | -9.53% |
| 24-05-30 | 5.14 | -6.88% |
| 24-05-29 | 5.52 | +61.88% |
| 24-05-28 | 3.41 | +4.60% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 04:43 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HD4898 |
| ISIN | DE000HD48989 |
| Date issued | 2024-03-28 |
| Maturity | 2024-09-18 (107 Days) |
| Parity | 1 : 1 |
| Emission price | 4.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.96 € |
|---|---|
| Lowest since issue | 1.6 € |
| Spread | 0.14 € |
| Spread % | 3.19% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- Certificat
